Decentralized Clinical Trials Capabilities and Solutions

Telemedicine – Decentralized Clinical Trial Patient Using Telemedicine

Telemedicine

Telemedicine enables patients to stay connected to their clinicians, utilizing convenient digital tools that don’t require frequent site visits. Sites can continue their standard of care, reduce protocol deviations, and collect quality data – all with limited interruption.

LEARN HOW TELEMEDICINE BENEFITS SITES AND PATIENTS WITH OUR VIDEO

SEE HOW WE’RE KEEPING STUDIES ON TRACK WITH TELEMEDICINE OPTIONS


Direct-to/from-patient models

When patients are unable to visit a site, clinical materials such as samples, supplies and unused investigational medicinal products (IMPs) can be directly shipped or collected from the patient’s home, so study assessments aren’t disrupted, nor are patients’ lives.

See how we’re keeping patients safe with a Direct-to-Patient (DTP) strategy
Direct-to and Direct-from Patient Models in Remote and Digital Clinical Trials

Remote eConsent – Patient Using Remote Consent in Decentralized Clinical Trial

REMOTE ECONSENT

Patients can securely review required study documents and provide a digital signature for consent (or re-consent) remotely from the comfort of their homes, so enrollment timelines stay on track, patients are better informed and compliance is maintained.

Learn how decentralization decreases patient burden with our webinar

Home Health Care & Nursing

PPD leverages a network of home health care (HHC) nurses in over 40 countries that enable clinical trials to occur off-site in the patient’s home. This includes the preparation and administration of study drugs, conducting clinical assessments, ensuring eDiary compliance and more.

READ ABOUT THE IMPORTANCE OF REDUCING PATIENT AND SITE BURDEN

INCREASE ENGAGEMENT AND RETENTION WITH OUR PATIENT CONCIERGE SERVICE

Home Health Care & Nursing – Patient Receiving Health Care at Home in Digital Trial

Patient using Electronic Clinical Outcomes Assessments (eCOAs) and electronic Patient Reported Outcomes (ePROs) Systems in a Decentralized Trial

eCOA and ePRO

Electronic clinical outcomes assessments (eCOAs) and electronic patient reported outcomes (ePROs) use digital platforms to enable direct data collection from study stakeholders. The result is less paper documentation and more timely data, with greater consistency from patients.

LEARN HOW eCOA CAN ACCELERATE CLINICAL RESEARCH WITH OUR VIDEO

SEE HOW YOU CAN INTEGRATE DIGITAL CLINICAL OUTCOME ASSESSMENTS INTO YOUR CLINICAL TRIALS (COAs)


Remote monitoring

When clinical research associates (CRAs) cannot physically be at an investigator site or clinic, remote options are available to generate data analytics, enable remote source data verification (rSDV) and perform other monitoring activities.

OPEN OUR SURVEY TO SEE WHAT 69% OF LIFE SCIENCE LEADERS THINK ABOUT REMOTE MONITORING AS A TOP STRATEGY

SEE HOW WE’RE DRIVING AGILE, PATIENT-CENTRIC CLINICAL TRIALS

Remote Monitoring and Data Capture in Decentralized Clinical Trials

Devices & Wearables – Patient Using Remote Monitoring and Data Capture Devices in a Clinical Trial

Devices and wearables

In today’s research, devices and wearable technologies are generating significantly higher levels of clinical data than traditional trial models. These sophisticated tools – smart phone and tablet apps, sports watches, meters and monitors, garments and textile patches – can be more convenient and less intrusive for patients as sites and sponsors seek higher quality insights.

Open our survey to see how 91% of clinical researchers feel about new platforms and technology

Regulatory Insights

Our regulatory affairs group provides guidance to support key business decisions around decentralized clinical trials (DCTs). Experts from these teams frequently share informal updates, describing hurdles faced by our industry, related regulatory issues and practical examples of how we manage them at PPD.

FDA LAUNCHES DIGITAL HEALTH CENTER OF EXCELLENCE

VIRTUAL TRIALS GAINING TRACTION IN THE EU

PANDEMIC SPEEDS ADOPTION OF TELEMEDICINE IN CLINICAL TRIALS

Regulatory Insights – Regulatory Affairs Guidance for Decentralized Clinical Trials.

Additional Resources

See more ways PPD can help with your decentralized clinical trials